By Gerald Flattmann, Evan Diamond, Vanessa Yen and Lucas Kressel, Paul Hastings LLP ( May 12, 2017, 2:53 PM EDT) -- On May 5, 2017, the U.S. Court of Appeals for the Federal Circuit issued a nonprecedential opinion reversing a decision of noninfringement under 35 U.S.C. § 271(e) by the U.S. District Court for the Southern District of New York. See Braintree Labs Inc. v. Breckenridge Pharm. Inc., No. 2016-1731 (Fed. Cir. May 5, 2017). Click here for the opinion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.